Drugs / Vi-DT Vaccine
Vi-DT Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03460405 | Jul 2018 → Dec 2019 | — | PT Bio Farma | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vi-DT Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03460405 ↗ |
| Known as | Vi-DT | “Investigational vaccine used was Vi-DT and control was Vi-PS.” PMID 38297337 ↗ Feb 2024 |
| Known as | Vi-DT Typhoid Conjugate Vaccine | “Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine” NCT03460405 ↗ |
| Modality | Vaccine | “Vi-DT conjugate vaccine” PMID 38297337 ↗ Feb 2024 |